Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Minerva Neurosciences, Inc - Common Stock
(NQ:
NERV
)
4.230
-0.370 (-8.04%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 29, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Minerva Neurosciences, Inc - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
Nasdaq Rises 50 Points; Lowe's Earnings Top Views
February 27, 2024
U.S. stocks traded mixed this morning, with the Nasdaq Composite gaining around 50 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.07% to 39,043.13 while the NASDAQ rose...
Via
Benzinga
Topics
Stocks
Minerva Neurosciences Receives Complete Response Letter from FDA for New Drug Application for Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia
February 27, 2024
From
Minerva Neurosciences, Inc
Via
GlobeNewswire
Minerva Neurosciences: Q4 Earnings Insights
February 22, 2024
Via
Benzinga
Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Business Updates
February 22, 2024
From
Minerva Neurosciences, Inc
Via
GlobeNewswire
Minerva Neurosciences Inc. (NASDAQ: NERV) Near the Top of Equities by Percentage Gain on 6/28
June 28, 2023
Via
Investor Brand Network
Earnings Preview For Minerva Neurosciences
May 12, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
February 08, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
February 05, 2024
Via
Benzinga
Minerva Neurosciences Reports 2023 Third Quarter Financial Results and Business Updates
November 07, 2023
From
Minerva Neurosciences, Inc
Via
GlobeNewswire
Minerva Neurosciences Reports 2023 Second Quarter Financial Results and Business Updates
August 01, 2023
From
Minerva Neurosciences, Inc
Via
GlobeNewswire
10 Short Squeeze Stocks To Watch: Baosheng Media, Toro Corp, Getty Images And More
July 18, 2023
Potential short squeeze plays gained steam in 2021, continued throughout 2022, and remain a focus of new traders looking for the next huge move. High short interest and steep borrowing costs are among...
Via
Benzinga
Top 5 Health Care Stocks That May Collapse This Quarter
July 10, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet
June 30, 2023
Investors are on the hunt for undervalued, underfollowed and emerging stocks, and retail traders have countless methods at their disposal to uncover new information. For some, this may be...
Via
Benzinga
BioXcel Therapeutics, Alvotech And Other Big Stocks Moving Lower On Thursday
June 29, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Thursday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Why Franklin Covey Shares Are Trading Higher By 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
June 29, 2023
Gainers Sigilon Therapeutics, Inc. (NASDAQ: SGTX) shares climbed 523.8% to $24.25 after Eli Lilly agreed to acquire the company for $14.92/share in cash.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
June 29, 2023
Via
Benzinga
Why CorMedix Are Trading Lower By 22%; Here Are 20 Stocks Moving Premarket
June 29, 2023
Gainers Eco Wave Power Global AB (NASDAQ: WAVE) shares surged 123% to $3.48 in pre-market trading after dropping over 8% on Wednesday.
Via
Benzinga
Crude Oil Rises Sharply; Unifirst Earnings Miss Expectations
June 28, 2023
U.S. stocks traded mixed toward the end of trading, with the Dow Jones dropping around 100 points on Wednesday. The Dow traded down 0.32% to 33,818.48 while the NASDAQ rose 0.23% to 13,586.93. The S&P...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
June 28, 2023
Via
Benzinga
Why Eton Pharmaceuticals Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
June 28, 2023
Gainers Minerva Neurosciences, Inc. (NASDAQ: NERV) surged 46.2% to $8.80. Minerva Neurosciences announced $20 million in private placement priced at a premium to market.
Via
Benzinga
Nasdaq Moves Higher; US Crude Stocks Drop More than Projected
June 28, 2023
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining over 80 points on Wednesday. The Dow traded down 0.42% to 33,784.59 while the NASDAQ rose 0.63% to 13,640.83. The S&P...
Via
Benzinga
Why Minerva Neurosciences Stock Is Shooting Higher Today
June 28, 2023
Minerva Neurosciences, Inc (NASDAQ: NERV) are shooting higher after the company bagged a $20 million investment from Boehringer Ingelheim and Federated Hermes Kaufmann Funds via
Via
Benzinga
Snowflake, Beazer Homes, Joby Aviation And Other Big Stocks Moving Higher On Wednesday
June 28, 2023
U.S. stocks traded lower, with the Dow Jones dropping over 100 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Dow Drops 100 Points; General Mills Posts Downbeat Sales
June 28, 2023
U.S. stocks traded lower this morning, with the Dow Jones dropping around 100 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.30% to 33,823.27 while the NASDAQ fell...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
June 28, 2023
Via
Benzinga
Minerva Neurosciences Announces $20 Million in Private Placement Priced at a Premium to Market
June 28, 2023
From
Minerva Neurosciences, Inc
Via
GlobeNewswire
Minerva Neurosciences Reports 2023 First Quarter Financial Results and Business Updates
May 15, 2023
Company to host conference call today at 8:30 a.m. ET
From
Minerva Neurosciences, Inc
Via
GlobeNewswire
Minerva Neurosciences Announces Update on its New Drug Application (NDA) for Roluperidone for the Treatment of Negative Symptoms in Schizophrenia
May 10, 2023
From
Minerva Neurosciences, Inc
Via
GlobeNewswire
Minerva Neurosciences to Report First Quarter 2023 Financial Results and Business Updates on May 15, 2023
May 08, 2023
Management to Host Conference Call
From
Minerva Neurosciences, Inc
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
May 01, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.